287 related articles for article (PubMed ID: 33989939)
1. CDKL5 deficiency disorder in males: Five new variants and review of the literature.
Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E
Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939
[TBL] [Abstract][Full Text] [Related]
2. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
[TBL] [Abstract][Full Text] [Related]
3. CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
Demarest ST; Olson HE; Moss A; Pestana-Knight E; Zhang X; Parikh S; Swanson LC; Riley KD; Bazin GA; Angione K; Niestroj LM; Lal D; Juarez-Colunga E; Benke TA
Epilepsia; 2019 Aug; 60(8):1733-1742. PubMed ID: 31313283
[TBL] [Abstract][Full Text] [Related]
4. X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.
Terzic B; Cui Y; Edmondson AC; Tang S; Sarmiento N; Zaitseva D; Marsh ED; Coulter DA; Zhou Z
Neurobiol Dis; 2021 Jan; 148():105176. PubMed ID: 33197557
[TBL] [Abstract][Full Text] [Related]
5. CDKL5 Deficiency Disorder Without Epilepsy.
Aznar-Laín G; Fernández-Mayoralas DM; Caicoya AG; Rocamora R; Pérez-Jurado LA
Pediatr Neurol; 2023 Jul; 144():84-89. PubMed ID: 37201242
[TBL] [Abstract][Full Text] [Related]
6. CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism.
Takahashi S; Takeguchi R; Tanaka R; Fukuoka M; Koike T; Ohtani H; Inoue K; Fukuda M; Kurahashi H; Nakamura K; Tominaga K; Matsubayashi T; Itoh M; Tanaka T
J Neurol Sci; 2022 Dec; 443():120498. PubMed ID: 36417806
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients.
Kluckova D; Kolnikova M; Medova V; Bognar C; Foltan T; Svecova L; Gnip A; Kadasi L; Soltysova A; Ficek A
Epilepsy Res; 2021 Oct; 176():106699. PubMed ID: 34229227
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.
Zhao Y; Zhang X; Bao X; Zhang Q; Zhang J; Cao G; Zhang J; Li J; Wei L; Pan H; Wu X
BMC Med Genet; 2014 Feb; 15():24. PubMed ID: 24564546
[TBL] [Abstract][Full Text] [Related]
9. Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.
Mulcahey PJ; Tang S; Takano H; White A; Davila Portillo DR; Kane OM; Marsh ED; Zhou Z; Coulter DA
Exp Neurol; 2020 Oct; 332():113388. PubMed ID: 32585155
[TBL] [Abstract][Full Text] [Related]
10. Wide range of phenotypic severity in individuals with late truncations unique to the predominant CDKL5 transcript in the brain.
Keehan L; Haviland I; Gofin Y; Swanson LC; El Achkar CM; Schreiber J; VanNoy GE; O'Heir E; O'Donnell-Luria A; Lewis RA; Magoulas P; Tran A; Azamian MS; Chao HT; Pham L; Samaco RC; Elsea S; Thorpe E; Kesari A; Perry D; Lee B; Lalani SR; Rosenfeld JA; Olson HE; Burrage LC;
Am J Med Genet A; 2022 Dec; 188(12):3516-3524. PubMed ID: 35934918
[TBL] [Abstract][Full Text] [Related]
11. Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
Amin S; Møller RS; Aledo-Serrano A; Arzimanoglou A; Bager P; Jóźwiak S; Kluger GJ; López-Cabeza S; Nabbout R; Partridge CA; Schubert-Bast S; Specchio N; Kälviäinen R
Epilepsia Open; 2024 Jun; 9(3):832-849. PubMed ID: 38450883
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD).
Chen PF; Chen T; Forman TE; Swanson AC; O'Kelly B; Dwyer SA; Buttermore ED; Kleiman R; Js Carrington S; Lavery DJ; Swanson LC; Olson HE; Sahin M
Stem Cell Res; 2021 May; 53():102276. PubMed ID: 33714067
[TBL] [Abstract][Full Text] [Related]
13. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
[TBL] [Abstract][Full Text] [Related]
14. CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description.
Pestana Knight EM; Olson HE
Am J Intellect Dev Disabil; 2024 Mar; 129(2):101-109. PubMed ID: 38411242
[TBL] [Abstract][Full Text] [Related]
15. Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.
Leonard H; Junaid M; Wong K; Demarest S; Downs J
Epilepsy Res; 2021 Jan; 169():106521. PubMed ID: 33341033
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
Olson HE; Demarest ST; Pestana-Knight EM; Swanson LC; Iqbal S; Lal D; Leonard H; Cross JH; Devinsky O; Benke TA
Pediatr Neurol; 2019 Aug; 97():18-25. PubMed ID: 30928302
[TBL] [Abstract][Full Text] [Related]
17. First report of Tunisian patients with CDKL5-related encephalopathy.
Charfi Triki C; Zouari Mallouli S; Ben Jdila M; Ben Said M; Kamoun Feki F; Weckhuysen S; Masmoudi S; Fakhfakh F
Epilepsia Open; 2024 Jun; 9(3):906-917. PubMed ID: 37701975
[TBL] [Abstract][Full Text] [Related]
18. CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.
Van Bergen NJ; Massey S; Quigley A; Rollo B; Harris AR; Kapsa RMI; Christodoulou J
Biochem Soc Trans; 2022 Aug; 50(4):1207-1224. PubMed ID: 35997111
[TBL] [Abstract][Full Text] [Related]
19. Key clinical features to identify girls with CDKL5 mutations.
Bahi-Buisson N; Nectoux J; Rosas-Vargas H; Milh M; Boddaert N; Girard B; Cances C; Ville D; Afenjar A; Rio M; Héron D; N'guyen Morel MA; Arzimanoglou A; Philippe C; Jonveaux P; Chelly J; Bienvenu T
Brain; 2008 Oct; 131(Pt 10):2647-61. PubMed ID: 18790821
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]